US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 6.440
  • +0.262+4.23%
Close Sep 13 16:00 ET
57.20MMarket Cap-107333P/E (TTM)

About Serina Therapeutics Company

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Company Profile

SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Websitehttp://serinatherapeutics.com/

Company Executives

  • Name
  • Position
  • Salary
  • Steven Ledger
  • Director and Chief Executive Officer
  • --
  • Gregory S. Curhan
  • Chief Financial Officer
  • --
  • Dr. Randall W. Moreadith,M.D.,PhD
  • Chief Scientific Officer
  • --
  • Dr. Srini Tenjarla, PhD
  • Senior Vice President, CMC and Formulation
  • --
  • Dr. Simba Gill, PhD
  • Chairman of the Board
  • --
  • Steven M. Mintz
  • Independent Director
  • --
  • J. Milton Harris, PhD
  • Independent Director
  • --
  • Remy Gross
  • Independent Director
  • --
  • Dr. Richard Marshall, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data